Last reviewed · How we verify
CNP-104
At a glance
| Generic name | CNP-104 |
|---|---|
| Sponsor | COUR Pharmaceutical Development Company, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CNP-104 CI brief — competitive landscape report
- CNP-104 updates RSS · CI watch RSS
- COUR Pharmaceutical Development Company, Inc. portfolio CI